KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Gains from Investment Securities (2016 - 2025)

Charles River Laboratories International (CRL) has 16 years of Gains from Investment Securities data on record, last reported at -$14.7 million in Q3 2024.

  • For Q3 2024, Gains from Investment Securities fell 199.34% year-over-year to -$14.7 million; the TTM value through Sep 2024 reached -$21.6 million, down 229.86%, while the annual FY2022 figure was $8.2 million, 418.62% up from the prior year.
  • Gains from Investment Securities reached -$14.7 million in Q3 2024 per CRL's latest filing, down from $14.8 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $23.6 million in Q4 2022 and bottomed at -$22.7 million in Q3 2023.
  • Average Gains from Investment Securities over 5 years is -$1.2 million, with a median of -$464000.0 recorded in 2021.
  • The widest YoY moves for Gains from Investment Securities: up 1539.84% in 2022, down 2268.3% in 2022.
  • A 5-year view of Gains from Investment Securities shows it stood at $11.7 million in 2020, then crashed by 114.07% to -$1.6 million in 2021, then surged by 1539.84% to $23.6 million in 2022, then crashed by 37.4% to $14.8 million in 2023, then tumbled by 199.34% to -$14.7 million in 2024.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$14.7 million in Q3 2024, $14.8 million in Q3 2023, and -$22.7 million in Q3 2023.